Edition:
United States

People: AbbVie Inc (ABBV.K)

ABBV.K on New York Consolidated

64.98USD
23 Sep 2016
Change (% chg)

$-0.10 (-0.15%)
Prev Close
$65.08
Open
$65.05
Day's High
$65.33
Day's Low
$64.75
Volume
5,154,154
Avg. Vol
8,001,101
52-wk High
$68.12
52-wk Low
$45.45

Severino, Michael 

Dr. Michael Severino, M.D., is the Executive Vice President - Research & Development and Chief Scientific Officer of the Company. Dr. Severino served at Amgen Inc. as Senior Vice President, Global Development and Corporate Chief Medical Officer from 2012 to 2014, as Vice President, Global Development from 2010 to 2012 and as Vice President, Therapeutic Area Head, General Medicine and Inflammation Global Clinical Development from 2007 to 2012.

Basic Compensation

Total Annual Compensation, USD 2,156,780
Restricted Stock Awards, USD 3,111,600
Long-Term Incentive Plans, USD --
All Other, USD 1,335,420
Fiscal Year Total, USD 6,603,800

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Gonzalez

19,192,400

William Chase

7,613,790

Michael Severino

6,603,800

Laura Schumacher

7,306,340

Carlos Alban

7,049,640

Henry Gosebruch

--
As Of  30 Dec 2015